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r7 -~- ]  Repair of Left Ventdcular Aneurysm- -  Clinical and 
Echocordlographle Long-Term Results of PIIcatlon 
Versus Endoaneurysmorrhaphy 
Oz M. Shsplre, Ravin Oaviduff, Robert J. Hilkerf, Gabriel S. Aides, Camel 
A. F~zgerald, Richard J. Shemin. Boston Unh, e~//y Medics/Center, Boston, 
MA 
Recently ventricular endoaneurysrnorrhaphy (EA) has replaced prP,.ation (PL) 
as the surgical procedure of choice for aneurysm repair. Them are little 
data comparing the two techr~lues. This study compared 27 patients who 
underwent EA with 20 patients who had PL. Mean age and NYHA functional 
class were 63.7 d: 9 years and 3.6 :E 0.5. The two groups matched with 
respect o age, gender, co-morbid dsks, NYHA class, urgency of the operation 
and frequency of concomitant procedures. Left venfficular function was worse 
in EA (LVEF: 25.0 :k 7.9% vs. 30.5 -4- 9.1%, p = 0.0066). Mean follow-up 
time In 44 patients (94%) was 41.0 • 26,5 months (range 3-86 months). 
To assess the geometric adaptation to s,Jrgery iong-term echeoardi~-ns 
were performed in 27 patients (EA-17, PL-10), and indeded measurements 
of LV volume, and LV sphericity (apical/mid4,V diameter atio and a spheddty 
index developed). 
PL(n=20) EA (n=27) p Valoe 
Operative mortalily 2(10%) 1 (3.7%) 0.9164 
Perloperattve complications 7 (~5%) 12 (44%) 0.1933 
5-year survival 56.5 :E 11.8% 66.9 :E 14.3"/o 0.4381 
Freedom from carcllac death 65.1 d: 11.9% as.6 4- 14.4% 0.3353 
Patients in NYHA class I/1! 53% 88% 0.0101 = 
Posl0p % Ir~ease in LVEF 17.6 ± 476% 51.3 4- 64.2"/(, 0.0360" 
LVvol (cc) 1as.9 ~ 54.4 171.6 :~ 59.1 0.9438 
Ap/Mid LV diameter ratio 0.79 :E 0.11 0.79 :E 0.09 1.0 
Sphericity index 0.61 4. 0.12 0.61 -~ 0.09 1.0 
Conduslon: Despite having a similar eitect on LV geometry, EA resulted in 
substantially improved long-term clinical outcome and improved LVER The 
mechanism remains to be expiored. 
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Shou ld  Mitral Regurgitation Surgery Be Performed 
in Minimally Symptomatic Patients? Analysis of the 
Impact of Class i l l - IV Symptoms on Postoperative 
Outcome 
Maurice E. Sarano, A. Jarnil Tajik, Hartzall V. Schaff, Thomas A. Crszulak, 
Robert I_ Frye. Mayo Clinic, Rochester, MN 
Severe symptoms remain the most usual indication for surgery in patients 
with mitral regurgitation. However, the impact of delaying surgery until class 
ftl Or W symptoms occur is not known. In 6~'~9 patients with mitrst regurgitation 
of organio etiology, 249 were operated in dass I or II and 390 in class til or 
IV between 1980 and 1991. As compared to patients with minimal symptoms 
(I-.-II) those with severe symptoms (III--JV) were older (6G ± 12 vs 61 ± 
13 yearn, p < 0.0001), had mote often atrial fibriflation (54=/0 vs 31%, p 
< 0.0001), a higher creattnine (1.3 :l: 0.6 vs 1.2 • 0.5. p < 0.015) and 
underwent frequently avalve repair (49% vs 71%, p < 0.0001 ). The outcome 
of surgery was net as good in patients with severe symptoms (lit-IV) as in 
those wigt minimal symptoms: postoperattve.'y, low cardiac output was more 
frequent (23% vs 9°/o, p < 0.0001), more days were spent in hospital (14 
± 13 vs 11:1:6 days, p < 0.0001) operative mortality was higher (7.7°/,, 
vs 1.6%, p = 0.0005). Also, *.he incidence of postoperative congestive heart 
failure was higher (at 5 yeats 21% vs 12%, p = 0.002) and survival was 
lower (at 5 years 71% vs 87%, p = 0.0001) in patients preoperatively inclass 
lll--lV. Alter stratifying for the baseline ditferenoss and the other predictors of 
outcome, in multivariate analysis the preoperative functional class remained 
an independent predictor of operative mortality (odds ratio 2~0, p = 0.009) 
and late survival (dsk ratio t.34, p = 0.003). In patients in class 1--41, younger 
than 75 years, operative mortality was only t%. 
We conclude that in patients with mitral regurgitation class Iti-lV symp- 
toms are independ9nt predictors of worse postoperative outcome of surgery. 
Therefore, in patients at a low operative risk and especially if repair is fea- 
sible, surgery should preferably be performed at an early stage with no or 
minimal symptoms. 
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Importanes of Associated A,eurysmal  Disease in 
the Long Term Care of Patier,~s With Ascending 
~ iC  An.eury.qms: Out. come of 392 Patients up to 
ears Aner uperauon 
Gem~d M. Lawde, Nan Earle, Michael E. DeBakey. Bay~or Col/age of 
Medicine, Houston, Texas 
Over a 40 year period 392 lots underwent graft replacement oi the as- 
(:ending aorta. The mean age was 49 ± 14 years. There were 302 (77%) 
males. Other aneurysms had been resected previously in 17 (4.3°/,,) tots: 10 
thoreclc/thoraco.alxIominal (TA), and 7 abdominal. Co existent aneurysma 
involved the arch in 51 pts (13.0%) descending aorta in 67 pts (6.7%), TA in 
34 pts (8.7%) and alxlominal aorta in 30 pts (6.7%). Pedoperatively, 13 fatal 
ruptures of other aneurysms Occurred. Long-term 67 subsequent aneurysms 
developed in 39 pts (9.9%). These consisted of descending: 13 pts, TA 10, 
abdominal: 14, arch; 7 and sinus of Valsalva in 13, peripheral in 8, and other 
2. Marian's syndrome was the dominant risk factor for subsequent aneurysm 
formation, acCOunting for 39% of subsequent eneurysms. Rupture of an un- 
diagnosed subsequent eneurysm caused 81 (29.6%) of late dest~ These 
data demonstrate the importance of complete evaluation of the ~orfa in Dts 
presenting with "isolated" ascending aneurysms and the need for diligent 
long-term foltow-up of the entire aorta by CT scan or MRI on a regular basis. 
5:00 
.Reduce! Mollality_end Morbidity for Ascending 
AOrtic Aneurysm Resection 
lawrence H. Cohn, Robert J. Rizzo, David H. Adams, SaJ"y F. Arenki, 
Gregory S. Couper, Nicole Benkel, John J. Collins, Jr.. Brigham and 
Women's Hospital, Boston, MA 
Recent advances have signif'ca~y improved the results ol asconding aortic 
anetm/sm surgery (AAA). We operated on 115 con~e patients with AAA 
(> 5 cm.), including Marfen's Syndrome, arteriosclerosis and post-stenotic 
dilatation from 1990 to 1995. 54 ~ (Group I) had v ~  conduit; 
Group II (46 patients) had aor~c valve replacement and supracaronary graft 
and Group III (15 patients) had only an ascending aortic graft. There were 62 
M and 53 F the mean age was 61. Reopemtions were dons in 15%, corenanj 
artery bypass grafting in 20% and 38% Of Group I had Marian's Syndrome. 
Operative mortality in Group I (valve-gt-aft conduit) was 1 of 54 (1.8%); in 
Group II, 1 of 46 (2°/=) and in Group III, 0. Overall, operative mortality was 
2 of 115 (1.7%). Postoperative incidence of b~eoding, non-fatal stroke and 
myocardial infarction was 3%, 2% and 1%, respectively. Length of stay in the 
past year has decreasod to < 7 hespital days. 
Operations on the ascending aneurysrnal aorta have a low mortality and 
morbidity due to improved control of hematologic factors, better myocardial 
protection and consistent use of transesophageal echocardiogram. 
5:15 
~ L a t e  Clinical and Functional Results After Left 
Ventricular Aneurysm Intracavitary Repair: 5 Years 
fo l low Up in 100 Patients 
Zvonimir Krajcar, Denton A. Cooley, Lt~',i Cuasay, MacArthur Elayda, 
Lovel Giunio. St Luke's Episcopal Hospital, and Texas Heart Institute, 
Houston, Texas 
Left ventfioJlar anesrysm intracavifary repair (LVAIR) is a new o ~  
technique which utilizes an endocardlal patch to exclude the aneurysm ard 
normalize LV geor~.  Between March 1989 end July 1991,100 patients un- 
delwent LVAIR with concomitfant coronary artery bypass graffing. To assess 
the immediate and long term clinical and functional results of the procedure 
we evaluated operative and late mortality, preoperative and postoperative 
functional NYHA class and ejection fra~on using nuclear ventriculogrsphy. 
The mean duration of ~iow up was 40 months (range 0 to 75 months). Eady 
mortality (within 30 days) was 4%. Functional class improved after LVAIR 
in 99% of patients, and ejection fraction improved signif'cantty in 68% of 
patients, Actuarial survival was 86% at one year, 84% at 2 years and 77% at 
6 years. Out of 50 patients who had preoperative, postoperative and follow 
up nuclear ventriculography, 84% showed continued improvement inejection 
fraction. 
MeanEF~Prsop ~± 7 ]p=O.O001 ] 
Mean EF%Poslop(<30days) 37~: 8 ]p=0.03 j p=0.0001 
Mean EF% Postop (>2 years) 41 ~ 10 
The results indicate that LVAIR is associated with low operative mortality, 
symptomatic reflef, improvement of left ventdcular function, and long term 
survival. Benefits continue 6 years postoperatively. 
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